Cargando…
Cell therapy with hiPSC-derived RPE cells and RPCs prevents visual function loss in a rat model of retinal degeneration
Photoreceptor loss is the principal cause of blindness in retinal degenerative diseases (RDDs). Whereas some therapies exist for early stages of RDDs, no effective treatment is currently available for later stages, and once photoreceptors are lost, the only option to rescue vision is cell transplant...
Autores principales: | Salas, Anna, Duarri, Anna, Fontrodona, Laura, Ramírez, Diana Mora, Badia, Anna, Isla-Magrané, Helena, Ferreira-de-Souza, Barbara, Zapata, Miguel Ángel, Raya, Ángel, Veiga, Anna, García-Arumí, José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937540/ https://www.ncbi.nlm.nih.gov/pubmed/33738324 http://dx.doi.org/10.1016/j.omtm.2021.02.006 |
Ejemplares similares
-
Comparative study of human embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPSC) as a treatment for retinal dystrophies
por: Riera, Marina, et al.
Publicado: (2016) -
Neovascular Progression and Retinal Dysfunction in the Laser-Induced Choroidal Neovascularization Mouse Model
por: Salas, Anna, et al.
Publicado: (2023) -
Multiocular organoids from human induced pluripotent stem cells displayed retinal, corneal, and retinal pigment epithelium lineages
por: Isla-Magrané, Helena, et al.
Publicado: (2021) -
Evaluation for Retinal Therapy for RPE65 Variation Assessed in hiPSC Retinal Pigment Epithelial Cells
por: Nash, Benjamin M., et al.
Publicado: (2021) -
All-trans retinoic acid modulates pigmentation, neuroretinal maturation, and corneal transparency in human multiocular organoids
por: Isla-Magrané, Helena, et al.
Publicado: (2022)